{
  "solution_stats": {
    "total_solutions": 4,
    "details": [
      {
        "solution_id": 1,
        "steps_count": 7
      },
      {
        "solution_id": 2,
        "steps_count": 5
      },
      {
        "solution_id": 3,
        "steps_count": 7
      },
      {
        "solution_id": 4,
        "steps_count": 12
      }
    ]
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule19",
              "prover9": "(A7 -> (-(A4 -> -A5) -> A6))",
              "prover9_expression": "(treats(disease_d) -> (-(approved_by(fda_agency) -> -causes_side_effects(substance_x)) -> requires_monitoring(device_w)))",
              "natural": "Provided that it treats disease D, then if it is not the case that if it was approved by the FDA agency then substance X does not cause side effects, then device W requires monitoring."
            },
            {
              "id": "Fact1",
              "prover9": "A7",
              "prover9_expression": "treats(disease_d)",
              "natural": "It treats disease D."
            }
          ],
          "conclusion": "(-(A4 -> -A5) -> A6)",
          "natural": "Provided that it is not the case that if it was approved by the FDA agency then substance X does not cause side effects, then device W requires monitoring."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A4 -> -A5) -> A6)",
              "prover9_expression": "(-(approved_by(fda_agency) -> -causes_side_effects(substance_x)) -> requires_monitoring(device_w))",
              "natural": "Provided that it is not the case that if it was approved by the FDA agency then substance X does not cause side effects, then device W requires monitoring."
            },
            {
              "id": "Rule29",
              "prover9": "(-(A4 -> -A5) -> -A6)",
              "prover9_expression": "(-(approved_by(fda_agency) -> -causes_side_effects(substance_x)) -> -requires_monitoring(device_w))",
              "natural": "Whenever it is not the case that if it was approved by the FDA agency then substance X does not cause side effects, then device W does not require monitoring."
            }
          ],
          "conclusion": "(A4 -> -A5)",
          "natural": "Under the condition that it was approved by the FDA agency, then substance X does not cause side effects."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule17",
              "prover9": "(A4 -> A5)",
              "prover9_expression": "(approved_by(fda_agency) -> causes_side_effects(substance_x))",
              "natural": "If it was approved by the FDA agency, then substance X causes side effects."
            },
            {
              "id": "Derived",
              "prover9": "(A4 -> -A5)",
              "prover9_expression": "(approved_by(fda_agency) -> -causes_side_effects(substance_x))",
              "natural": "Under the condition that it was approved by the FDA agency, then substance X does not cause side effects."
            }
          ],
          "conclusion": "-A4",
          "natural": "It is not the case that it was approved by the FDA agency."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule18",
              "prover9": "(A4 | (-(-A1 -> A2) -> A3))",
              "prover9_expression": "(approved_by(fda_agency) | (-(-researched(substance_x) -> published_on(platform_y)) -> tested_on(animal_model_z)))",
              "natural": "It was approved by the FDA agency or if it is not the case that if substance X was not researched then it was published on platform Y, then it was tested on animal model Z."
            },
            {
              "id": "Derived",
              "prover9": "-A4",
              "prover9_expression": "-approved_by(fda_agency)",
              "natural": "It is not the case that it was approved by the FDA agency."
            }
          ],
          "conclusion": "(-(-A1 -> A2) -> A3)",
          "natural": "Provided that it is not the case that if substance X was not researched then it was published on platform Y, then it was tested on animal model Z."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(-A1 -> A2) -> A3)",
              "prover9_expression": "(-(-researched(substance_x) -> published_on(platform_y)) -> tested_on(animal_model_z))",
              "natural": "Provided that it is not the case that if substance X was not researched then it was published on platform Y, then it was tested on animal model Z."
            },
            {
              "id": "Rule31",
              "prover9": "(-(-A1 -> A2) -> -A3)",
              "prover9_expression": "(-(-researched(substance_x) -> published_on(platform_y)) -> -tested_on(animal_model_z))",
              "natural": "Under the condition that it is not the case that if substance X was not researched then it was published on platform Y, then it was not tested on animal model Z."
            }
          ],
          "conclusion": "(-A1 -> A2)",
          "natural": "If substance X was not researched, then it was published on platform Y."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-A1 -> A2)",
              "prover9_expression": "(-researched(substance_x) -> published_on(platform_y))",
              "natural": "If substance X was not researched, then it was published on platform Y."
            },
            {
              "id": "Fact4",
              "prover9": "-A2",
              "prover9_expression": "-published_on(platform_y)",
              "natural": "It is not the case that the research was published on platform Y."
            }
          ],
          "conclusion": "A1",
          "natural": "Substance X has been researched."
        },
        {
          "step_number": 7,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule1",
              "prover9": "(A1 -> G)",
              "prover9_expression": "(researched(substance_x) -> beneficial_to_patients(substance_x))",
              "natural": "Provided that substance X has been researched, then it follows that it is beneficial to patients."
            },
            {
              "id": "Derived",
              "prover9": "A1",
              "prover9_expression": "researched(substance_x)",
              "natural": "Substance X has been researched."
            }
          ],
          "conclusion": "G",
          "natural": "Substance X is beneficial to patients."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule22",
              "prover9": "(-(A10 | -A9) -> A12)",
              "prover9_expression": "(-(fails_clinical_trial(substance_x) | -shows_efficacy(substance_x)) -> withdrawn_from_market(substance_x))",
              "natural": "Provided that it is not the case that either substance X fails clinical trial or it does not show efficacy, then it is withdrawn from market."
            },
            {
              "id": "Rule2",
              "prover9": "(A12 -> -A11)",
              "prover9_expression": "(withdrawn_from_market(substance_x) -> -requires_modification(device_w))",
              "natural": "Whenever substance X is withdrawn from market, then device W does not require modification."
            }
          ],
          "conclusion": "(-(A10 | -A9) -> -A11)",
          "natural": "Under the condition that it is not the case that either substance X fails clinical trial or it does not show efficacy, then device W does not require modification."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule21",
              "prover9": "(-(A10 | -A9) -> A11)",
              "prover9_expression": "(-(fails_clinical_trial(substance_x) | -shows_efficacy(substance_x)) -> requires_modification(device_w))",
              "natural": "If it is not the case that either substance X fails clinical trial or it does not show efficacy, then device W requires modification."
            },
            {
              "id": "Derived",
              "prover9": "(-(A10 | -A9) -> -A11)",
              "prover9_expression": "(-(fails_clinical_trial(substance_x) | -shows_efficacy(substance_x)) -> -requires_modification(device_w))",
              "natural": "Under the condition that it is not the case that either substance X fails clinical trial or it does not show efficacy, then device W does not require modification."
            }
          ],
          "conclusion": "(A10 | -A9)",
          "natural": "Either substance X fails clinical trial or it is not the case that it shows efficacy."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A10 | -A9)",
              "prover9_expression": "(fails_clinical_trial(substance_x) | -shows_efficacy(substance_x))",
              "natural": "Either substance X fails clinical trial or it is not the case that it shows efficacy."
            },
            {
              "id": "Fact2",
              "prover9": "-A10",
              "prover9_expression": "-fails_clinical_trial(substance_x)",
              "natural": "It is not the case that substance X fails clinical trial."
            }
          ],
          "conclusion": "-A9",
          "natural": "It is not the case that substance X shows efficacy."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule20",
              "prover9": "(A9 | (-G -> -A8))",
              "prover9_expression": "(shows_efficacy(substance_x) | (-beneficial_to_patients(substance_x) -> -exhibits_toxicity(substance_x)))",
              "natural": "Substance X shows efficacy or if it is not the case that it is beneficial to patients then it does not exhibit toxicity."
            },
            {
              "id": "Derived",
              "prover9": "-A9",
              "prover9_expression": "-shows_efficacy(substance_x)",
              "natural": "It is not the case that substance X shows efficacy."
            }
          ],
          "conclusion": "(-G -> -A8)",
          "natural": "If it is not the case that substance X is beneficial to patients, then it does not exhibit toxicity."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule32",
              "prover9": "(-G -> A8)",
              "prover9_expression": "(-beneficial_to_patients(substance_x) -> exhibits_toxicity(substance_x))",
              "natural": "Provided that it is not the case that substance X is beneficial to patients, then it exhibits toxicity."
            },
            {
              "id": "Derived",
              "prover9": "(-G -> -A8)",
              "prover9_expression": "(-beneficial_to_patients(substance_x) -> -exhibits_toxicity(substance_x))",
              "natural": "If it is not the case that substance X is beneficial to patients, then it does not exhibit toxicity."
            }
          ],
          "conclusion": "G",
          "natural": "Substance X is beneficial to patients."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule24",
              "prover9": "(-(A21 -> -A18) -> A22)",
              "prover9_expression": "(-(faces_regulatory_hurdles(substance_x) -> -generates_revenue(substance_x)) -> undergoes_review(device_w))",
              "natural": "Whenever it is not the case that if substance X faces regulatory hurdles then it does not generate revenue, then device W undergoes review."
            },
            {
              "id": "Rule25",
              "prover9": "(-(A21 -> -A18) -> -A22)",
              "prover9_expression": "(-(faces_regulatory_hurdles(substance_x) -> -generates_revenue(substance_x)) -> -undergoes_review(device_w))",
              "natural": "If it is not the case that if substance X faces regulatory hurdles then it does not generate revenue, then device W does not undergo review."
            }
          ],
          "conclusion": "(A21 -> -A18)",
          "natural": "If substance X faces regulatory hurdles, then it does not generate revenue."
        },
        {
          "step_number": 2,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule8",
              "prover9": "(A20 -> A19)",
              "prover9_expression": "(demonstrates_cost_effectiveness(substance_x) -> attracts_investment(project_p))",
              "natural": "Provided that substance X demonstrates cost effectiveness, then project P attracts investment."
            },
            {
              "id": "Derived",
              "prover9": "(A21 -> -A18)",
              "prover9_expression": "(faces_regulatory_hurdles(substance_x) -> -generates_revenue(substance_x))",
              "natural": "If substance X faces regulatory hurdles, then it does not generate revenue."
            },
            {
              "id": "Rule9",
              "prover9": "(A20 | A21)",
              "prover9_expression": "(demonstrates_cost_effectiveness(substance_x) | faces_regulatory_hurdles(substance_x))",
              "natural": "Substance X demonstrates cost effectiveness or it faces regulatory hurdles."
            }
          ],
          "conclusion": "(A19 | -A18)",
          "natural": "Project P attracts investment or it is not the case that substance X generates revenue."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A19 | -A18)",
              "prover9_expression": "(attracts_investment(project_p) | -generates_revenue(substance_x))",
              "natural": "Project P attracts investment or it is not the case that substance X generates revenue."
            },
            {
              "id": "Fact3",
              "prover9": "-A19",
              "prover9_expression": "-attracts_investment(project_p)",
              "natural": "It is not the case that project P attracts investment."
            }
          ],
          "conclusion": "-A18",
          "natural": "It is not the case that substance X generates revenue."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule30",
              "prover9": "(-(-(A15 -> A13) -> -A17) -> A18)",
              "prover9_expression": "(-(-(completes_phase_ii(substance_x) -> passes_safety_test(substance_x)) -> -receives_funding(project_p)) -> generates_revenue(substance_x))",
              "natural": "If it is not the case that if it is not the case that if substance X completes phase II then it passes safety test then project P does not receive funding, then substance X generates revenue."
            },
            {
              "id": "Derived",
              "prover9": "-A18",
              "prover9_expression": "-generates_revenue(substance_x)",
              "natural": "It is not the case that substance X generates revenue."
            }
          ],
          "conclusion": "(-(A15 -> A13) -> -A17)",
          "natural": "Provided that it is not the case that if substance X completes phase II then it passes safety test, then project P does not receive funding."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule23",
              "prover9": "(-(A15 -> A13) -> A17)",
              "prover9_expression": "(-(completes_phase_ii(substance_x) -> passes_safety_test(substance_x)) -> receives_funding(project_p))",
              "natural": "If it is not the case that if substance X completes phase II then it passes safety test, then project P receives funding."
            },
            {
              "id": "Derived",
              "prover9": "(-(A15 -> A13) -> -A17)",
              "prover9_expression": "(-(completes_phase_ii(substance_x) -> passes_safety_test(substance_x)) -> -receives_funding(project_p))",
              "natural": "Provided that it is not the case that if substance X completes phase II then it passes safety test, then project P does not receive funding."
            }
          ],
          "conclusion": "(A15 -> A13)",
          "natural": "Provided that substance X completes phase II, then it passes safety test."
        },
        {
          "step_number": 6,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A15 -> A13)",
              "prover9_expression": "(completes_phase_ii(substance_x) -> passes_safety_test(substance_x))",
              "natural": "Provided that substance X completes phase II, then it passes safety test."
            },
            {
              "id": "Rule6",
              "prover9": "(A16 -> A14)",
              "prover9_expression": "(enters_phase_iii(substance_x) -> shows_promise(substance_x))",
              "natural": "If substance X enters phase III, then it shows promise."
            },
            {
              "id": "Rule5",
              "prover9": "(A15 | A16)",
              "prover9_expression": "(completes_phase_ii(substance_x) | enters_phase_iii(substance_x))",
              "natural": "Either substance X completes phase II or it enters phase III."
            }
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Substance X passes safety test or it shows promise."
        },
        {
          "step_number": 7,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A13 | A14)",
              "prover9_expression": "(passes_safety_test(substance_x) | shows_promise(substance_x))",
              "natural": "Substance X passes safety test or it shows promise."
            },
            {
              "id": "Rule3",
              "prover9": "(A13 -> G)",
              "prover9_expression": "(passes_safety_test(substance_x) -> beneficial_to_patients(substance_x))",
              "natural": "If substance X passes safety test, then it is beneficial to patients."
            },
            {
              "id": "Rule4",
              "prover9": "(A14 -> G)",
              "prover9_expression": "(shows_promise(substance_x) -> beneficial_to_patients(substance_x))",
              "natural": "Under the condition that substance X shows promise, then it is beneficial to patients."
            }
          ],
          "conclusion": "G",
          "natural": "Substance X is beneficial to patients."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule27",
              "prover9": "(-(A30 -> A31) -> A32)",
              "prover9_expression": "(-(has_methodological_flaws(study_results) -> needs_replication(study_results)) -> requires_peer_review(study_results))",
              "natural": "Under the condition that it is not the case that if study results have methodological flaws then they need replication, then they require peer review."
            },
            {
              "id": "Rule28",
              "prover9": "(-(A30 -> A31) -> -A32)",
              "prover9_expression": "(-(has_methodological_flaws(study_results) -> needs_replication(study_results)) -> -requires_peer_review(study_results))",
              "natural": "If it is not the case that if study results have methodological flaws then they need replication, then they do not require peer review."
            }
          ],
          "conclusion": "(A30 -> A31)",
          "natural": "Whenever study results have methodological flaws, then they need replication."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A30 -> A31)",
              "prover9_expression": "(has_methodological_flaws(study_results) -> needs_replication(study_results))",
              "natural": "Whenever study results have methodological flaws, then they need replication."
            },
            {
              "id": "Rule16",
              "prover9": "(A31 -> (A27 -> -A28))",
              "prover9_expression": "(needs_replication(study_results) -> (creates_confusion(study_results) -> -provides_clarity(study_results)))",
              "natural": "Provided that study results need replication, then if they create confusion, they do not provide clarity."
            }
          ],
          "conclusion": "(A30 -> (A27 -> -A28))",
          "natural": "If study results have methodological flaws, then provided that they create confusion, they do not provide clarity."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule15",
              "prover9": "(A29 | A30)",
              "prover9_expression": "(contains_contradictions(study_results) | has_methodological_flaws(study_results))",
              "natural": "Study results contain contradictions or they have methodological flaws."
            },
            {
              "id": "Rule14",
              "prover9": "(A29 -> (A27 -> -A28))",
              "prover9_expression": "(contains_contradictions(study_results) -> (creates_confusion(study_results) -> -provides_clarity(study_results)))",
              "natural": "Under the condition that study results contain contradictions, then if they create confusion, they do not provide clarity."
            },
            {
              "id": "Derived",
              "prover9": "(A30 -> (A27 -> -A28))",
              "prover9_expression": "(has_methodological_flaws(study_results) -> (creates_confusion(study_results) -> -provides_clarity(study_results)))",
              "natural": "If study results have methodological flaws, then provided that they create confusion, they do not provide clarity."
            }
          ],
          "conclusion": "(A27 -> -A28)",
          "natural": "Provided that study results create confusion, then they do not provide clarity."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule13",
              "prover9": "(A27 -> A28)",
              "prover9_expression": "(creates_confusion(study_results) -> provides_clarity(study_results))",
              "natural": "If study results create confusion, then they provide clarity."
            },
            {
              "id": "Derived",
              "prover9": "(A27 -> -A28)",
              "prover9_expression": "(creates_confusion(study_results) -> -provides_clarity(study_results))",
              "natural": "Provided that study results create confusion, then they do not provide clarity."
            }
          ],
          "conclusion": "-A27",
          "natural": "It is not the case that study results create confusion."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule26",
              "prover9": "(-(A26 -> A24) -> A27)",
              "prover9_expression": "(-(prevents_progression(disease_d) -> improves_patient_outcomes(substance_x)) -> creates_confusion(study_results))",
              "natural": "Provided that it is not the case that if it prevents progression of disease D then substance X improves patient outcomes, then study results create confusion."
            },
            {
              "id": "Derived",
              "prover9": "-A27",
              "prover9_expression": "-creates_confusion(study_results)",
              "natural": "It is not the case that study results create confusion."
            }
          ],
          "conclusion": "(A26 -> A24)",
          "natural": "Whenever it prevents progression of disease D, then substance X improves patient outcomes."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule12",
              "prover9": "(A25 | A26)",
              "prover9_expression": "(reduces_symptoms(disease_d) | prevents_progression(disease_d))",
              "natural": "It reduces symptoms of disease D or it prevents progression of disease D."
            },
            {
              "id": "Rule11",
              "prover9": "(A25 -> A24)",
              "prover9_expression": "(reduces_symptoms(disease_d) -> improves_patient_outcomes(substance_x))",
              "natural": "Provided that it reduces symptoms of disease D, then substance X improves patient outcomes."
            },
            {
              "id": "Derived",
              "prover9": "(A26 -> A24)",
              "prover9_expression": "(prevents_progression(disease_d) -> improves_patient_outcomes(substance_x))",
              "natural": "Whenever it prevents progression of disease D, then substance X improves patient outcomes."
            }
          ],
          "conclusion": "A24",
          "natural": "Substance X improves patient outcomes."
        },
        {
          "step_number": 7,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule10",
              "prover9": "(A24 -> -A23)",
              "prover9_expression": "(improves_patient_outcomes(substance_x) -> -achieves_commercial_success(substance_x))",
              "natural": "Under the condition that substance X improves patient outcomes, then it does not achieve commercial success."
            },
            {
              "id": "Derived",
              "prover9": "A24",
              "prover9_expression": "improves_patient_outcomes(substance_x)",
              "natural": "Substance X improves patient outcomes."
            }
          ],
          "conclusion": "-A23",
          "natural": "It is not the case that substance X achieves commercial success."
        },
        {
          "step_number": 8,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule7",
              "prover9": "(A18 -> A23)",
              "prover9_expression": "(generates_revenue(substance_x) -> achieves_commercial_success(substance_x))",
              "natural": "Whenever substance X generates revenue, then it achieves commercial success."
            },
            {
              "id": "Derived",
              "prover9": "-A23",
              "prover9_expression": "-achieves_commercial_success(substance_x)",
              "natural": "It is not the case that substance X achieves commercial success."
            }
          ],
          "conclusion": "-A18",
          "natural": "It is not the case that substance X generates revenue."
        },
        {
          "step_number": 9,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule30",
              "prover9": "(-(-(A15 -> A13) -> -A17) -> A18)",
              "prover9_expression": "(-(-(completes_phase_ii(substance_x) -> passes_safety_test(substance_x)) -> -receives_funding(project_p)) -> generates_revenue(substance_x))",
              "natural": "If it is not the case that if it is not the case that if substance X completes phase II then it passes safety test then project P does not receive funding, then substance X generates revenue."
            },
            {
              "id": "Derived",
              "prover9": "-A18",
              "prover9_expression": "-generates_revenue(substance_x)",
              "natural": "It is not the case that substance X generates revenue."
            }
          ],
          "conclusion": "(-(A15 -> A13) -> -A17)",
          "natural": "Provided that it is not the case that if substance X completes phase II then it passes safety test, then project P does not receive funding."
        },
        {
          "step_number": 10,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule23",
              "prover9": "(-(A15 -> A13) -> A17)",
              "prover9_expression": "(-(completes_phase_ii(substance_x) -> passes_safety_test(substance_x)) -> receives_funding(project_p))",
              "natural": "If it is not the case that if substance X completes phase II then it passes safety test, then project P receives funding."
            },
            {
              "id": "Derived",
              "prover9": "(-(A15 -> A13) -> -A17)",
              "prover9_expression": "(-(completes_phase_ii(substance_x) -> passes_safety_test(substance_x)) -> -receives_funding(project_p))",
              "natural": "Provided that it is not the case that if substance X completes phase II then it passes safety test, then project P does not receive funding."
            }
          ],
          "conclusion": "(A15 -> A13)",
          "natural": "Provided that substance X completes phase II, then it passes safety test."
        },
        {
          "step_number": 11,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A15 -> A13)",
              "prover9_expression": "(completes_phase_ii(substance_x) -> passes_safety_test(substance_x))",
              "natural": "Provided that substance X completes phase II, then it passes safety test."
            },
            {
              "id": "Rule6",
              "prover9": "(A16 -> A14)",
              "prover9_expression": "(enters_phase_iii(substance_x) -> shows_promise(substance_x))",
              "natural": "If substance X enters phase III, then it shows promise."
            },
            {
              "id": "Rule5",
              "prover9": "(A15 | A16)",
              "prover9_expression": "(completes_phase_ii(substance_x) | enters_phase_iii(substance_x))",
              "natural": "Either substance X completes phase II or it enters phase III."
            }
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Substance X passes safety test or it shows promise."
        },
        {
          "step_number": 12,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A13 | A14)",
              "prover9_expression": "(passes_safety_test(substance_x) | shows_promise(substance_x))",
              "natural": "Substance X passes safety test or it shows promise."
            },
            {
              "id": "Rule3",
              "prover9": "(A13 -> G)",
              "prover9_expression": "(passes_safety_test(substance_x) -> beneficial_to_patients(substance_x))",
              "natural": "If substance X passes safety test, then it is beneficial to patients."
            },
            {
              "id": "Rule4",
              "prover9": "(A14 -> G)",
              "prover9_expression": "(shows_promise(substance_x) -> beneficial_to_patients(substance_x))",
              "natural": "Under the condition that substance X shows promise, then it is beneficial to patients."
            }
          ],
          "conclusion": "G",
          "natural": "Substance X is beneficial to patients."
        }
      ]
    }
  ]
}